Selective Estrogen Receptor Degraders Therapeutic Market: How Are...

добавлена новая статья Health

2026-07-28 09:55:54 -

Selective Estrogen Receptor Degraders Therapeutic Market: How Are SERDs Reshaping Endocrine Therapy Beyond the Limitations of Tamoxifen and Aromatase Inhibitors?

Selective estrogen receptor degraders — the next-generation endocrine agents that bind the estrogen receptor and induce its conformational change, ubiquitination, and proteasomal degradation rather than merely blocking estrogen binding — represent the most significant mechanistic advance in hormone receptor-positive breast cancer therapy since the introduction of aromatase...

0 Комментарии 0 Поделились 555 Просмотры 0 предпросмотр